Editors Overview

rtid maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Focus and Scope

About the Journal

Recent Trends in Infectious Diseases is a peer-reviewed open-access journal launched in 2023 that are a significant global health challenge, with outbreaks and epidemics occurring frequently, and new diseases emerging. Recent trends in infectious diseases have highlighted the importance of understanding the transmission, diagnosis, and treatment of these diseases. This paper aims to provide an overview of the current state of infectious diseases, recent trends, and future directions.

The recent trends in infectious diseases focus on, emerging and re-emerging infections, zoonotic diseases, the impact of climate change, and the increasing problem of antimicrobial resistance. The paper will cover both human and animal infectious diseases, with a focus on the mechanisms of transmission, prevention, and treatment.

Papers Published


Publication Charge
Open Access

Focus and Scope

  • Emerging and re-emerging infectious diseases: Outbreaks, Pandemics, Epidemics, Emerging infectious diseases (EIDs), Re-emerging infectious diseases (RIDs), Novel viruses, Zoonoses, Reservoirs, Hosts, Vector-borne, Influenza, Coronaviruses, Ebola, Zika, Chikungunya, MERS (Middle East Respiratory Syndrome), Nipah virus, Hantavirus, Avian influenza (bird flu), SARS (Severe Acute Respiratory Syndrome), Malaria, Dengue fever, Cholera, Tuberculosis, Antimicrobial resistance.
  • Zoonotic diseases: Zoonosis, Animal-borne diseases, Animal-human transmission, Reservoir hosts, Wildlife diseases, Vector-borne diseases, Emerging zoonotic diseases, Re-emerging zoonotic diseases, Rabies, Avian influenza (bird flu), Swine flu, Ebola, Marburg virus, Lassa fever, Hendra virus, Nipah virus, Brucellosis, Lyme disease, West Nile virus, Plague, Hantavirus, Q fever, Leptospirosis, Tularemia, Salmonella.
  • Climate change and infectious diseases: Climate change, Global warming, Vector-borne diseases, Mosquito-borne diseases, Tick-borne diseases, Malaria, Dengue fever, Chikungunya, Zika virus, Yellow fever, West Nile virus, Lyme disease, Rocky Mountain spotted fever, Hantavirus, Rodent-borne diseases, Water-borne diseases, Cholera, Diarrheal diseases, Cryptosporidiosis, Leptospirosis, Melioidosis, Heat waves, Extreme weather events, Air pollution, Climate adaptation.
  • Antimicrobial resistance: Antibiotic resistance, Antimicrobial resistance (AMR), Superbugs, Multi-drug resistance, Resistance genes, Bacteria, Viruses, Fungi, Parasites, Overuse of antibiotics, Misuse of antibiotics, Antibiotic stewardship, Hospital-acquired infections, Community-acquired infections, Methicillin-resistant Staphylococcus aureus (MRSA), Carbapenem-resistant Enterobacteriaceae (CRE), Vancomycin-resistant Enterococci (VRE), Extended-spectrum beta-lactamase (ESBL), Mycobacterium tuberculosis, Clostridium difficile, Pneumococcal infections, Gonorrhea, Tuberculosis, Malaria, Drug development.
  • Diagnosis and treatment: Medical diagnosis, Differential diagnosis, Laboratory tests, Imaging tests, Physical examination, Biopsy, Treatment, Drug therapy, Surgery, Radiation therapy, Chemotherapy, Immunotherapy, Gene therapy, Stem cell therapy, Palliative care, Clinical trials, Therapeutic efficacy, Pharmacotherapy, Combination therapy, Personalized medicine, Precision medicine, Therapeutic drug monitoring, Adverse drug reactions, Drug interactions, Drug resistance.


  • Emerging infectious diseases
  • Re-emerging infectious diseases
  • Zoonotic diseases
  • Antimicrobial resistance
  • Pandemics
  • Outbreaks
  • Vector-borne diseases
  • Climate change
  • One Health approach
  • Genomics
  • Vaccines
  • Immunization
  • Digital health
  • Artificial intelligence (AI)
  • Big data
  • Global health security
  • Travel medicine
  • Neglected tropical diseases
  • Disease surveillance
  • Diagnostics
  • Treatment innovations
  • Pathogen genomics
  • Public health policies
  • Drug development
  • Health Equity

Open Access Statement

The Recent Trends in Infectious Diseases (rtid) is an open-access (OA) publication which provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. All published works will be available to a worldwide audience, free, immediately upon publication. Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licenses.

Publication Ethics Statement

rtid fully adhere to Code of Conduct of Publication Ethics (COPE) and to its Best Practice Guidelines. The Editorial Team enforces a rigorous peer-review process with strict ethical policies and standards to ensure the addition of high-quality scientific studies to the field of scholarly publication. In cases where rtid becomes aware of ethical issues, it is committed to investigating and taking necessary actions to maintain the integrity of the literature and ensure the safety of research participants. Click here to read more about the Research & Publication virtue ethics

Content Disclaimer

  • All the information’s, opinions, and views mentioned here represents the authors and the contributions of the articles.
  • Publication of articles, advertisements, or product information does not constitute endorsement or approval by the journal.
  • Cannot be help responsible for any error or consequences while using the information updated in this journal.
  • Although every effort is done by rtid to see that there’s no any inaccurate data, misleading data, opinion or statement within the journal, the data and opinions appearing in the articles are the responsibility of the contributors concerned.